Hypothesis / aims of study
The main intention of this research was to provide a new approach for birth-injury induced stress urinary incontinence (SUI), focusing on bone marrow stem cell (BMSC) secretions and fibroblast contribution. With increasing acknowledgment of the potential role of BMSC secretions in angiogenesis, tissue repair, immunomodulation, and anti-fibrotic, we hope to determine if BMSC secretions activate anterior vaginal wall fibroblasts (AVWFs), which play an important role in the progress of delivery associated SUI.
Study design, materials and methods
Primary fibroblasts were extracted from anterior vaginal wall tissues of patient with SUI and vaginal prolapse, and identified by immunofluorescence staining. BMSC conditioned medium (BMSC-CM), which contains all secretions of BMSC, was collected and purified after two-day culture in serum-free medium. The effects of BMSC-CM in AVWFs proliferation and migration were respectively assessed by CCK8 assay and cell-scratch test compared with fibroblast-CM and serum-free medium. Reverse transcription-quantitative polymerase chain reaction (RT-PCR) and western blot were used to detect the expression of collagen I and III and the activation of signal pathway. In vivo, 15 SD rats were divided into 3 groups and received vaginal distention (VD) + periurethral injection of BMSC-CM, VD + periurethral injection of control medium, or sham VD. Leak point pressure (LPP) and periurethral histology were observed 2 weeks later.
Interpretation of results
BMSC secretions (a combination of growth factors, cytokines and chemokines) successfully promote activation of anterior vaginal wall fibroblasts, which may contribute to functional and anatomic recovery of birth-injury caused stress incontinence simulated by vaginal distention.